Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GIVOSIRAN for Porphyria acute: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 676 adverse event reports in the FDA FAERS database where GIVOSIRAN was used for Porphyria acute.

Most Reported Side Effects for GIVOSIRAN

Side Effect Reports % Deaths Hosp.
Porphyria acute 381 31.1% 2 245
Hospitalisation 141 11.5% 0 141
Nausea 91 7.4% 0 38
Product dose omission issue 85 6.9% 2 60
Fatigue 84 6.9% 0 29
Therapy interrupted 83 6.8% 0 65
Pain 74 6.1% 1 48
Intentional dose omission 63 5.2% 0 48
Abdominal pain 62 5.1% 0 35
Vomiting 58 4.7% 0 37
Malaise 56 4.6% 0 32
Seizure 48 3.9% 0 15
Ill-defined disorder 40 3.3% 0 17
Weight decreased 40 3.3% 0 26
Blood homocysteine increased 39 3.2% 0 10

Other Indications for GIVOSIRAN

Product used for unknown indication (394) Porphyria (148) Porphyria non-acute (5)

Other Drugs Used for Porphyria acute

HEMIN (161) BUSULFAN (13) FLUDARABINE (11) ALEMTUZUMAB (9) DEXTROSE (9) HEME (9) PROMETHAZINE (6) CIMETIDINE (5) MORPHINE (5) RANITIDINE (5)

Related Pages

GIVOSIRAN Full Profile All Porphyria acute Drugs GIVOSIRAN Demographics GIVOSIRAN Timeline